Habiba Elfandy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Habiba Elfandy has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
- Christopher E. Barbieri
Department of Urology, Weill Cornell Medicine, New York, USA
11 shared publications Eli Pullman
11 shared publications- Filippo Pederzoli
Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA
11 shared publications - Konrad H. Stopsack
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts
11 shared publications - Massimo Loda
Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, USA
11 shared publications Mirjam Blattner
11 shared publications
Latest Publications
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Figure S4 from Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate
Invasive Cribriform Carcinoma is Associated with High Gleason Score and Tumor Stage.
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate
Invasive Cribriform Carcinoma is Associated with High Gleason Score and Tumor Stage.
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figures S1-S6 from Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate
Supplemental figure 1: Examples of cribriform and noncribriform carcinoma; Supplemental figure 2: Scheme of Sample Selection; Supplemental figure 3: Examples of PTEN Immunostaining of Tissue Microarray (TMA) Cores, HPFS/ PHS Prostate Cancer Cohorts; Supplementary figure 4: Invasive Cribriform Carcinoma is Associated with High Gleason Score and Tumor Stage (TCGA datasets); Supplementary figure 5. Difference in FGA between Cribriform Carcinoma (ICC) and Noncribriform Carcinoma (NC4) as well as between Gleason scores (in TCGA dataset); Supplementary figure 6: Cribriform Morphology in PTENloss and SPOPmut Transgenic Mouse Prostate Model.
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figures S1-S6 from Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate
Supplemental figure 1: Examples of cribriform and noncribriform carcinoma; Supplemental figure 2: Scheme of Sample Selection; Supplemental figure 3: Examples of PTEN Immunostaining of Tissue Microarray (TMA) Cores, HPFS/ PHS Prostate Cancer Cohorts; Supplementary figure 4: Invasive Cribriform Carcinoma is Associated with High Gleason Score and Tumor Stage (TCGA datasets); Supplementary figure 5. Difference in FGA between Cribriform Carcinoma (ICC) and Noncribriform Carcinoma (NC4) as well as between Gleason scores (in TCGA dataset); Supplementary figure 6: Cribriform Morphology in PTENloss and SPOPmut Transgenic Mouse Prostate Model.
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Table S11 from Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate
Function and aberration of differentially methylated genes between Cribriform and noncribriform.
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessTable S11 from Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate
Function and aberration of differentially methylated genes between Cribriform and noncribriform.
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Table S4 from Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate
Table S4: Function and effect of aberration of SCNV genes associated with cribriform morphology.
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessTable S4 from Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate
Table S4: Function and effect of aberration of SCNV genes associated with cribriform morphology.
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Table S5, S6, S7 from Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate
Table S5: Top-ranked mutation events in Cribriform Carcinoma (ICC), arranged by p-values; Table S6: Overexpressed and underexpressed genes in Cribriform Carcinoma (ICC); Table 7: Upregulated and down regulated gene sets and pathways in cribriform carcinoma (ICC).
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessTable S5, S6, S7 from Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate
Table S5: Top-ranked mutation events in Cribriform Carcinoma (ICC), arranged by p-values; Table S6: Overexpressed and underexpressed genes in Cribriform Carcinoma (ICC); Table 7: Upregulated and down regulated gene sets and pathways in cribriform carcinoma (ICC).
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Figure S5 from Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate
Difference in FGA between Cribriform Carcinoma (ICC) and Noncribriform Carcinoma (NC4) as well as between Gleason scores.
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate
Difference in FGA between Cribriform Carcinoma (ICC) and Noncribriform Carcinoma (NC4) as well as between Gleason scores.
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Table S8 from Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate
Function and effect of aberrations of differentially expressed genes between Cribriform and Noncribriform
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessTable S8 from Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate
Function and effect of aberrations of differentially expressed genes between Cribriform and Noncribriform
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Figure S6 from Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate
Cribriform Morphology in PTENloss and SPOPmut Transgenic Mouse Prostate Model
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate
Cribriform Morphology in PTENloss and SPOPmut Transgenic Mouse Prostate Model
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Table S9, S10 from Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate
Table S9: Differentially methylated CpG islands in invasive cribriform vs Noncribriform; Table S10: mRNA expression of the differentially hypermethylated in cribriform with concomitant reduction of mRNA expression.
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessTable S9, S10 from Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate
Table S9: Differentially methylated CpG islands in invasive cribriform vs Noncribriform; Table S10: mRNA expression of the differentially hypermethylated in cribriform with concomitant reduction of mRNA expression.
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Table S1, S2, S3 from Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate
Table S1: IDs of Cribriform (ICC) & Non-cribriform (NC4) TCGA cases; Table S2: Comparison between cribriform and non-cribriform based on TCGA clusters; Table S3: Somatic Copy Number Variation (SCNV) enriched in Cribriform Carcinoma (ICC) compared to Noncribriform (NC4), corrected for Fraction Genome Altered (FGA) and Gleason Score (GS).
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1, S2, S3 from Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate
Table S1: IDs of Cribriform (ICC) & Non-cribriform (NC4) TCGA cases; Table S2: Comparison between cribriform and non-cribriform based on TCGA clusters; Table S3: Somatic Copy Number Variation (SCNV) enriched in Cribriform Carcinoma (ICC) compared to Noncribriform (NC4), corrected for Fraction Genome Altered (FGA) and Gleason Score (GS).